Literature DB >> 28891710

The use of a thyroid shield for intraoral anterior oblique occlusal views-a risk-based approach.

Mark Worrall1, Alison Menhinick2, Donald J Thomson3.   

Abstract

OBJECTIVES: To estimate the radiation dose reduction to the thyroid for an anterior oblique occlusal view from the use of a thyroid shield, compare this with the variation in thyroid dose resulting from differences in examination positioning and discuss the additional considerations associated with the use of a thyroid shield before making a recommendation on their routine use for this examination.
METHODS: Doses to the oral mucosa, the salivary glands, the thyroid, the extrathoracic airways, the oesophagus and the lungs were directly measured for anterior oblique occlusal X-rays of a Rando phantom with and without a thyroid shield using strips of calibrated XRQA Gafchromic film. The examination was also simulated using Monte Carlo software for the without thyroid shield case for a comparison of the dose and to evaluate the dosimetric effect of suboptimal examination positioning.
RESULTS: A 36% reduction in thyroid dose was measured as a result of thyroid shield use; the effective dose reduction is of the order of 22%. Suboptimal positioning was found to increase thyroid dose by a far more significant amount.
CONCLUSIONS: Despite the reduction in thyroid dose, cost-benefit considerations mean that the purchase of a thyroid shield is only recommended where a very high number of anterior oblique occlusal views are undertaken. Optimization efforts for this examination are better focussed on training in examination positioning.

Entities:  

Keywords:  Radiography; thyroid gland

Mesh:

Year:  2017        PMID: 28891710      PMCID: PMC5965737          DOI: 10.1259/dmfr.20170140

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  15 in total

1.  [The use of a thyroid collar for intraoral radiography].

Authors:  K Schmidt; X L Velders; F C van Ginkel; P F van der Stelt
Journal:  Ned Tijdschr Tandheelkd       Date:  1998-06

2.  Reference dosimetry during diagnostic CT examination using XR-QA radiochromic film model.

Authors:  Jonathan Boivin; Nada Tomic; Bassam Fadlallah; Francois Deblois; Slobodan Devic
Journal:  Med Phys       Date:  2011-09       Impact factor: 4.071

3.  NCRP report No. 145: New dental X-ray guidelines: their potential impact on your dental practice.

Authors:  Dale A Miles; Robert P Langlais
Journal:  Dent Today       Date:  2004-09

4.  Dose reduction in maxillofacial imaging using low dose Cone Beam CT.

Authors:  Kostas Tsiklakis; Catherine Donta; Sophia Gavala; Kety Karayianni; Vasiliki Kamenopoulou; Costas J Hourdakis
Journal:  Eur J Radiol       Date:  2005-06-22       Impact factor: 3.528

5.  Dosimetry of 3 CBCT devices for oral and maxillofacial radiology: CB Mercuray, NewTom 3G and i-CAT.

Authors:  J B Ludlow; L E Davies-Ludlow; S L Brooks; W B Howerton
Journal:  Dentomaxillofac Radiol       Date:  2006-07       Impact factor: 2.419

6.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

7.  Scanning orientation and polarization effects for XRQA radiochromic film.

Authors:  Hani Alnawaf; Martin J Butson; Tsang Cheung; Peter K N Yu
Journal:  Phys Med       Date:  2010-02-10       Impact factor: 2.685

8.  Visual and numerical methods to measure patient skin doses in interventional procedures using radiochromic XR-RV2 films.

Authors:  R Sánchez; E Vano; J M Fernández; A Machado; N Roas
Journal:  Radiat Prot Dosimetry       Date:  2011-07-13       Impact factor: 0.972

9.  Developing a method and deriving an uncertainty budget for the internal calibration of dosemeters for radiographic equipment.

Authors:  M Worrall; D G Sutton
Journal:  J Radiol Prot       Date:  2015-02-04       Impact factor: 1.394

10.  Patient entrance surface dose measurements using XR-QA2 Gafchromic films during micturating cystourethrography procedures.

Authors:  K Soliman; A Alenezi
Journal:  Radiat Prot Dosimetry       Date:  2013-09-30       Impact factor: 0.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.